A multi-institutional study led by the Icahn School of Medicine at Mount Sinai reports one-third of patients with relapsed or ...

The dual-targeting CAR T-cell therapy KITE-363 showed positive response rates and manageable side effects in relapsed or ...

Alfred L. Garfall, MD, provided a deep dive into the phase 2 BMT CTN 1902 trial of ide-cel in multiple myeloma after ...

The dramatic bend in the curve of cancer deaths didn’t happen by accident — it’s the compound interest of three revolutions.

AstraZeneca targets $80bn revenue by 2030, driven by oncology and new drugs, but faces patent risks and tough competition.

The Trump administration’s freezing of $790 million in federal research funding for Northwestern University has left ...

A revolutionary immunotherapy has stunned doctors by making an aggressive, previously incurable blood cancer vanish in some ...

A Hampshire hotel is set to offer a new groundbreaking facial treatment. Lime Wood Hotel in the New Forest will be the first in England to offer the GROUND Biome Facial at its Herb House spa, using a ...